Dec. 5, 2012

Host: Peter Ravdin, M.D., Ph.D., director of the Breast Health Clinic at the CTRC, hosted a press conference featuring the following research:

• Higher Doses of Fulvestrant Prolonged Survival in Patients With Advanced Breast Cancer
• Combination of Investigational Agent and Letrozole Demonstrated Clinical Benefit in Advanced ER-positive Breast Cancer
• Sentinel Lymph Node Surgery After Chemotherapy Demonstrated Accuracy in Nodal Staging for Certain Patients With Breast Cancer
• Black Women Less Likely to Receive Improved Surgical Procedure for Breast Cancer
• Extending Duration of Adjuvant Tamoxifen to 10 Years Reduced Risk for Late Breast Cancer Recurrence, Improved Survival

Listen to the teleconference or download* the mp3 of the teleconference (5.21 MB, 45:24 minutes)

*On a PC, right mouse click on the "download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.

Page updated: Dec. 5, 2012